PET biodistribution study of subcutaneous and intravenous administration of adalimumab in an inflammatory bowel disease model.
Codesido J, García-Varela L, García-Otero X, Bouzón-Barreiro S, Gómez-Lado N, Toja-Camba FJ, Mondelo-García C, Lazaré H, Torres JB, Vidal-Otero J, Medin-Aguerre S, Sanchez-Crespo A, Otero-Espinar FJ, Herance JR, Fernández-Ferreiro A, Aguiar P.
Codesido J, et al. Among authors: toja camba fj.
Int J Pharm. 2024 Nov 29;669:125011. doi: 10.1016/j.ijpharm.2024.125011. Online ahead of print.
Int J Pharm. 2024.
PMID: 39617190